554
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Is HBV prophylaxis required during CLL treatment with ibrutinib?

, , , &
Pages 2966-2968 | Received 12 Jan 2017, Accepted 31 Mar 2017, Published online: 23 May 2017
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (2.4 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.